Biological markers: Tailoring treatment and trials to prognosis

Biological markers: Tailoring treatment and trials to prognosis

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	Kerr, D, Shi, Y
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Biological markers: Tailoring treatment and trials to prognosis
od: Kerr, D, i dr.
Izdano: (2013)

The Correlation Between Biological Markers and Prognosis in Thyroid Cancer
od: Rami Hajjar, i dr.
Izdano: (2024-12-01)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
od: Edouard Louis
Izdano: (2020-01-01)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
od: Psallidas, I, i dr.
Izdano: (2016)

Tailored Biologics Selection in Severe Asthma
od: Sang Hyuk Kim, i dr.
Izdano: (2024-01-01)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
od: Domingo, E, i dr.
Izdano: (2018)

Markers of oncological prognosis in the surgical treatment of oral squamous cell carcinoma
od: A. I. Stukan, i dr.
Izdano: (2024-04-01)

NOVEL OPTICAL PROTEOMICS MOLECULARLY PROFILES BREAST CANCER PATIENTS LEADING TO INDIVIDUALISED PROGNOSIS AND TAILORED TREATMENT
od: Kelleher, M, i dr.
Izdano: (2009)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
od: Noseworthy, J, i dr.
Izdano: (1983)

Tailor treatment to the patient in stable angina.
od: Taggart, D
Izdano: (2011)

Tailored carbon-based nanomaterials for biological energy electrocatalysis
od: Quinson, J
Izdano: (2015)

An evaluation of tailored psychological treatment of insomnia.
od: Espie, C, i dr.
Izdano: (1989)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
od: Xueting Hu, i dr.
Izdano: (2022-07-01)

N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma
od: Jiehua Deng, i dr.
Izdano: (2022-12-01)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial.
od: Lennox, A, i dr.
Izdano: (2001)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial
od: Lennox, A, i dr.
Izdano: (2001)

CAPS markers in plant biology
od: Y. N. Shavrukov
Izdano: (2015-07-01)

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
od: Domingo, E, i dr.
Izdano: (2018)

Toward neuromarkers for tailored smoking cessation treatments
od: Francesco Versace, i dr.
Izdano: (2023-06-01)

Tailoring surfaces : modifying surface composition and structure for applications in tribology, biology and catalysis /
od: 511742 Spencer, Nicholas D.
Izdano: (c201)

Single-cell analyses to tailor treatments
od: Benson, Mikael, i dr.
Izdano: (2018)

Correction: Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled Trial
od: Halse, Rhiannon E, i dr.
Izdano: (2020-12-01)

Computational design of anti-cancer peptides tailored to target specific tumor markers
od: Aisha Naeem, i dr.
Izdano: (2024-02-01)

Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment.
od: Yajia Chen, i dr.
Izdano: (2025-01-01)

New Biological Markers of Bone Metabolism in Osteoporosis Treatment
od: Sun Wook Cho
Izdano: (2016-09-01)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
od: Johnstone, E, i dr.
Izdano: (2008)

The modified coughlin osteotomy for surgical treatment of high-grade tailor’s bunion
od: Shi-Ming Feng MD
Izdano: (2018-09-01)

Tailored nanocrystal catalysts
od: Zhao, Y
Izdano: (2023)

Tailoring Biologic Therapies for Pediatric Severe Asthma: A Comprehensive Approach
od: Claudia María Chaverri Repáraz, i dr.
Izdano: (2025-01-01)

Tailoring two-dimensional nanomaterials by structural engineering for chemical and biological sensing
od: Bo Zhang, i dr.
Izdano: (2020-11-01)

Tailored Base Surge Policy for Middle Echelon in Biologics Supply Chain
od: Pedroni, David
Izdano: (2022)

PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
od: H. Charfi, i dr.
Izdano: (2022-06-01)

Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment
od: Laura Pérez-Cano, i dr.
Izdano: (2024-04-01)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
od: Caroline Y. K. Fong, i dr.
Izdano: (2019-01-01)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
od: Ulmert, D, i dr.
Izdano: (2009)

Pleomorphic Liposarcoma Unraveled: Investigating Histopathological and Immunohistochemical Markers for Tailored Diagnosis and Therapeutic Innovations
od: Ana-Maria Ciongariu, i dr.
Izdano: (2024-06-01)

Tailoring treatment for locally advanced rectal cancer
od: Laudy Chehade, i dr.
Izdano: (2024-01-01)

Commentary: Treatment for Truncus Arteriosus Needs to Be Tailored
od: Hong-Gook Lim
Izdano: (2023-03-01)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
od: Christina-Nefeli Kontandreopoulou, i dr.
Izdano: (2022-10-01)

Tailored liposomal nanotraps for the treatment of Streptococcal infections
od: Hervé Besançon, i dr.
Izdano: (2021-02-01)